Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma

By afschroeder • February 2, 2026

Robatel S, Hillen H, Mutisheva I, Müller JC, Wartenberg M, Ma F, Bäriswyl L, Evenepoel J, Scheele CLGJ, Lee DJ, Modlin RL, Kessler U, Nobis M, Z'graggen K, Schenk M. Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma. J Gastroenterol. 2026 Feb 1. doi: 10.1007/s00535-026-02347-y. Epub ahead of print. PMID: 41620983.

Tags: Dermatology, Harbor UCLA, Immunomodulation, immunotherapy, pancreatic ductal adenocarcinoma, Publications, Transcriptomics, tumor microenvironment

Merkel Cell Carcinoma Masquerading as Dermatitis

Freeman M, Gates G, Ahronowitz I. Merkel Cell Carcinoma Masquerading as Dermatitis. Cureus. 2026 Sep 19;18(9):e116561. doi: 10.7759/cureus.116561. PMID: 42903405; PMCID: PMC13680730.

Ethical Implications of Patient-Requested Cessation of Mohs Micrographic Surgery with Residual Tumor

Ajmani A, Sanjeev R, Klufas T, Zhou AE, Davis JC, Grant-Kels JM. Ethical Implications of Patient-Requested Cessation of Mohs Micrographic Surgery with Residual Tumor. J[...]

Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials

McInnes IB, Stein Gold L, Bissonnette R, Lebwohl MG, Reyes-Servin O, Cafone J, Yang YW, Chakravarty SD, Iaconangelo C, Li S, Shagroni T, Lozenski K,[...]